vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

BLACKBERRY Ltd is the larger business by last-quarter revenue ($141.8M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). BLACKBERRY Ltd runs the higher net margin — 9.7% vs -38.1%, a 47.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BB vs PRCT — Head-to-Head

Bigger by revenue
BB
BB
1.7× larger
BB
$141.8M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+21.0% gap
PRCT
20.2%
-0.8%
BB
Higher net margin
BB
BB
47.7% more per $
BB
9.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.8%
BB

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
BB
BB
PRCT
PRCT
Revenue
$141.8M
$83.1M
Net Profit
$13.7M
$-31.6M
Gross Margin
77.5%
64.9%
Operating Margin
8.4%
-4.1%
Net Margin
9.7%
-38.1%
Revenue YoY
-0.8%
20.2%
Net Profit YoY
224.5%
-27.9%
EPS (diluted)
$0.02
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$141.8M
$76.4M
Q3 25
$129.6M
$83.3M
Q2 25
$121.7M
$79.2M
Q1 25
$141.7M
$69.2M
Q4 24
$143.6M
$68.2M
Q3 24
$126.2M
$58.4M
Q2 24
$123.4M
$53.4M
Net Profit
BB
BB
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$13.7M
$-29.8M
Q3 25
$13.3M
$-21.4M
Q2 25
$1.9M
$-19.6M
Q1 25
$-7.4M
$-24.7M
Q4 24
$-10.5M
$-18.9M
Q3 24
$-19.7M
$-21.0M
Q2 24
$-41.4M
$-25.6M
Gross Margin
BB
BB
PRCT
PRCT
Q1 26
64.9%
Q4 25
77.5%
60.6%
Q3 25
74.5%
64.8%
Q2 25
74.2%
65.4%
Q1 25
73.5%
63.9%
Q4 24
78.1%
64.0%
Q3 24
70.2%
63.2%
Q2 24
72.9%
59.0%
Operating Margin
BB
BB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
8.4%
-40.6%
Q3 25
8.9%
-27.8%
Q2 25
1.6%
-28.0%
Q1 25
-5.6%
-39.7%
Q4 24
13.6%
-28.9%
Q3 24
1.7%
-38.4%
Q2 24
-10.5%
-50.3%
Net Margin
BB
BB
PRCT
PRCT
Q1 26
-38.1%
Q4 25
9.7%
-39.1%
Q3 25
10.3%
-25.7%
Q2 25
1.6%
-24.7%
Q1 25
-5.2%
-35.8%
Q4 24
-7.3%
-27.6%
Q3 24
-15.6%
-35.9%
Q2 24
-33.5%
-48.0%
EPS (diluted)
BB
BB
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.02
$-0.54
Q3 25
$0.02
$-0.38
Q2 25
$0.00
$-0.35
Q1 25
$-0.01
$-0.45
Q4 24
$-0.02
$-0.34
Q3 24
$-0.03
$-0.40
Q2 24
$-0.07
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$304.2M
$245.6M
Total DebtLower is stronger
$196.2M
$51.7M
Stockholders' EquityBook value
$741.1M
$347.7M
Total Assets
$1.2B
$487.1M
Debt / EquityLower = less leverage
0.26×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$304.2M
$286.5M
Q3 25
$290.5M
$294.3M
Q2 25
$306.6M
$302.7M
Q1 25
$337.8M
$316.2M
Q4 24
$220.0M
$333.7M
Q3 24
$211.0M
$196.8M
Q2 24
$229.0M
$214.1M
Total Debt
BB
BB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$196.2M
$51.6M
Q3 25
$195.9M
$51.6M
Q2 25
$195.6M
$51.5M
Q1 25
$195.3M
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
BB
BB
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$741.1M
$365.9M
Q3 25
$725.1M
$380.3M
Q2 25
$725.1M
$385.8M
Q1 25
$719.9M
$389.2M
Q4 24
$725.2M
$402.2M
Q3 24
$732.1M
$241.2M
Q2 24
$742.6M
$251.8M
Total Assets
BB
BB
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.2B
$508.1M
Q3 25
$1.2B
$511.5M
Q2 25
$1.2B
$513.1M
Q1 25
$1.3B
$519.4M
Q4 24
$1.3B
$534.0M
Q3 24
$1.3B
$374.1M
Q2 24
$1.3B
$374.4M
Debt / Equity
BB
BB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.26×
0.14×
Q3 25
0.27×
0.14×
Q2 25
0.27×
0.13×
Q1 25
0.27×
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
PRCT
PRCT
Operating Cash FlowLast quarter
$18.3M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
PRCT
PRCT
Q1 26
Q4 25
$18.3M
$-10.3M
Q3 25
$3.9M
$-6.6M
Q2 25
$-18.0M
$-15.0M
Q1 25
$41.6M
$-17.0M
Q4 24
$6.0M
$-32.4M
Q3 24
$-16.0M
$-18.8M
Q2 24
$-15.1M
$-15.7M
Free Cash Flow
BB
BB
PRCT
PRCT
Q1 26
Q4 25
$17.4M
$-12.2M
Q3 25
$3.1M
$-9.5M
Q2 25
$-18.9M
$-17.8M
Q1 25
$41.2M
$-18.8M
Q4 24
$5.2M
$-33.6M
Q3 24
$-16.5M
$-19.0M
Q2 24
$-16.5M
$-16.8M
FCF Margin
BB
BB
PRCT
PRCT
Q1 26
Q4 25
12.3%
-15.9%
Q3 25
2.4%
-11.4%
Q2 25
-15.5%
-22.5%
Q1 25
29.1%
-27.2%
Q4 24
3.6%
-49.2%
Q3 24
-13.1%
-32.6%
Q2 24
-13.4%
-31.4%
Capex Intensity
BB
BB
PRCT
PRCT
Q1 26
Q4 25
0.6%
2.4%
Q3 25
0.6%
3.4%
Q2 25
0.7%
3.5%
Q1 25
0.3%
2.7%
Q4 24
0.6%
1.7%
Q3 24
0.4%
0.4%
Q2 24
1.1%
2.0%
Cash Conversion
BB
BB
PRCT
PRCT
Q1 26
Q4 25
1.34×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons